Printer Friendly
The Free Library
19,607,053 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cyanotech Reports Increased Demand for Its Products.


Business Editors

KAILUA-KONA, Hawaii--(BUSINESS WIRE)--Dec. 20, 1999

Cyanotech Corporation (Nasdaq NMS See NetWare Management System. :CYAN), the world leader in producing high-value, natural products from microalgae, today reported that orders for the third quarter of fiscal 2000, ending December 31, 1999, are expected to exceed $2 million, which represents an increase of more than 30% over the second quarter of fiscal 2000.

"Demand for both Spirulina spirulina

Any cyanobacteria in the genus Spirulina. A traditional food source in parts of Africa and Mexico, spirulina is an exceptionally rich source of vitamins, minerals, and protein, and one of the few nonanimal sources of vitamin B12.
 Pacifica(TM) and natural astaxanthin are increasing and we have put previously idled capacity back into production to supply these orders," said Gerald R. Cysewski, Ph.D., Cyanotech chairman, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. .

Cyanotech Corporation produces high-value natural products from microalgae. Products include BioAstin(TM), a new natural astaxanthin product for use as a human nutritional supplement; NatuRose(TM) natural astaxanthin used in the worldwide aquaculture aquaculture, the raising and harvesting of fresh- and saltwater plants and animals. The most economically important form of aquaculture is fish farming, an industry that accounts for an ever increasing share of world fisheries production.  and animal feed industry; Spirulina Pacifica(TM), a nutrient-rich dietary supplement Noun 1. dietary supplement - something added to complete a diet or to make up for a dietary deficiency
diet - a prescribed selection of foods

vitamin pill - a pill containing one or more vitamins; taken as a dietary supplement
; and phycobiliproteins, which are fluorescent pigments used in the immunological diagnostics market. Cyanotech is the only microalgae company in the world to have an ISO (1) See ISO speed.

(2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI.
 9002 Registered Quality System. Additional information is available at http://www.cyanotech.com

(Note -- Information on factors that may affect the business and financial results of Cyanotech and may cause actual results to differ from current expectations can be found in filings of the Company with the Securities and Exchange Commission.)
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 20, 1999
Words:216
Previous Article:MetaCreations Releases Carrara, Next-Generation 3D Software for Print, Video and the Web.
Next Article:CTS Corporation Elects Walter S. Catlow to Board of Directors.
Topics:



Related Articles
Cyanotech Reports Financial Results for Fiscal 1999.
FDA Review Allows Cyanotech to Market BioXanthin Natural Astaxanthin for Human Nutrition in the United States.
Cyanotech Expects Minimal Impact From U.S. District Court Denial of Motion for Summary Judgment.
Cyanotech Reports Financial Results for the Third Quarter of Fiscal 2000.
Cyanotech Initiates Clinical Trial of BioAstin for Relief of Carpal Tunnel Syndrome.
Cyanotech Reports Continuing Demand for Its Products.
Cyanotech Reports Financial Results for the 4th Quarter and Fiscal 2000; 4th Quarter Sales Increase 28%, Net Loss Narrowed.
Cyanotech Receives FDA Approval for Its NatuRose Salmon Feed Ingredient.
Cyanotech Reports Third Quarter Fiscal 2001 Financial Results; Initiation of Second Clinical Trial for BioAstin Announced.
Cyanotech Announces Clinical Trial Results for BioAstin; BioAstin Prevents Knee and Joint Soreness and Increases Immune System Response after...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles